Sweden · Delayed Price · Currency is SEK SpectraCure AB Statistics
Total Valuation
SpectraCure AB has a market cap or net worth of SEK 30.24 million. The enterprise value is 15.83 million.
| Market Cap | 30.24M |
| Enterprise Value | 15.83M |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SpectraCure AB has 570.60 million shares outstanding. The number of shares has increased by 334.12% in one year.
| Current Share Class | 570.60M |
| Shares Outstanding | 570.60M |
| Shares Change (YoY) | +334.12% |
| Shares Change (QoQ) | +49.35% |
| Owned by Insiders (%) | 6.04% |
| Owned by Institutions (%) | 2.15% |
| Float | 535.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -299.43 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.78 |
| Quick Ratio | 1.71 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -46.89 |
Financial Efficiency
Return on equity (ROE) is -55.64% and return on invested capital (ROIC) is -33.19%.
| Return on Equity (ROE) | -55.64% |
| Return on Assets (ROA) | -30.41% |
| Return on Invested Capital (ROIC) | -33.19% |
| Return on Capital Employed (ROCE) | -54.92% |
| Weighted Average Cost of Capital (WACC) | 9.23% |
| Revenue Per Employee | -7,769 |
| Profits Per Employee | -4.30M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SpectraCure AB has paid 46,000 in taxes.
| Income Tax | 46,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.25% in the last 52 weeks. The beta is 0.47, so SpectraCure AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -86.25% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 30.98 |
| Average Volume (20 Days) | 4,095,992 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SpectraCure AB had revenue of SEK -101,000 and -55.90 million in losses. Loss per share was -0.13.
| Revenue | -101,000 |
| Gross Profit | 12.61M |
| Operating Income | -55.15M |
| Pretax Income | -55.86M |
| Net Income | -55.90M |
| EBITDA | -55.36M |
| EBIT | -55.15M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 16.59 million in cash and 2.19 million in debt, with a net cash position of 14.41 million or 0.03 per share.
| Cash & Cash Equivalents | 16.59M |
| Total Debt | 2.19M |
| Net Cash | 14.41M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 100.41M |
| Book Value Per Share | 0.16 |
| Working Capital | 8.21M |
Cash Flow
In the last 12 months, operating cash flow was -23.16 million and capital expenditures -37,000, giving a free cash flow of -23.19 million.
| Operating Cash Flow | -23.16M |
| Capital Expenditures | -37,000 |
| Depreciation & Amortization | -218,000 |
| Net Borrowing | -2.39M |
| Free Cash Flow | -23.19M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | 54,599.01% |
| Pretax Margin | 55,302.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SpectraCure AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -334.12% |
| Shareholder Yield | -334.12% |
| Earnings Yield | -184.85% |
| FCF Yield | -76.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |